Expanded Access Consultancy

“Providing access to life-saving drugs for unmet clinical needs”

Expanded Access Programs (EAPs) are rapidly becoming an important part of any successful development plan for pre-approval drugs. However, it can be hard to understand how these programs work and how best to implement one to meet your company’s needs.   

WEP Clinical has the experience and expertise to help guide you as you consider the Expanded Access use of your products. There are multiple elements involved in running a successful EAP, and WEP can support you every step of the way with the following:

  • How and why to set up an EAP
  • In-house versus outsourcing
  • Stakeholder engagement
  • Patient and country selection
  • Regulatory requirements and relevant new legislation
  • Charging for a drug
  • Stopping your EAP & Exit strategy

For more information contact:
+1 919 694 5088
+44 208 004 8186